Pluri Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount
Pluri Inc. (PLUR) reported Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount of ILS 2900.00 trillion for the 12-month period ending 2023-06-30, per its 10-K filed 2023-09-12.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsForeign · last filed 2023-09-12
- Pluri Inc. effective income tax rate reconciliation, tax credit, foreign, amount for fiscal 2023 was 2900.00T ILS, a 28999900.00% increase from fiscal 2022.
- Pluri Inc. effective income tax rate reconciliation, tax credit, foreign, amount for fiscal 2022 was 10.00B ILS, a 0.00% change from fiscal 2021.
- Pluri Inc. effective income tax rate reconciliation, tax credit, foreign, amount for fiscal 2021 was 10.00B ILS, a 0.00% change from fiscal 2020.
- Pluri Inc. effective income tax rate reconciliation, tax credit, foreign, amount for fiscal 2020 was 10.00B ILS.
ILS
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount 12 month |
|---|---|
| 2023-06-30 | 2900.00T ILS 10-K · filed 2023-09-12 |
| 2022-06-30 | 10.00B ILS 10-K · filed 2022-09-21 |
| 2021-06-30 | 10.00B ILS 10-K · filed 2021-09-13 |
| 2020-06-30 | 10.00B ILS 10-K · filed 2020-09-10 |
USD
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount 12 month |
|---|---|
| 2022-06-30 | $2.90B 10-K · filed 2022-09-21 |
| 2021-06-30 | $2.90B 10-K · filed 2021-09-13 |
| 2020-06-30 | $2.90B 10-K · filed 2020-09-10 |
| 2019-06-30 | $2.90B 10-K · filed 2019-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |